IREN Limited (IREN) Balance Sheet
As of 2026-06-30 (10-K), IREN Limited (IREN) reported total assets of $15.8B, total liabilities of $11.6B and shareholders' equity of $4.2B, according to EquiReason's reading of its SEC filings. Cash and equivalents: $7.6B. Long-term debt: $7.4B.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
IRENIREN LimitedFollow IREN — free
—
Price chart with a free account
- Market cap
- 9.8B
- P/E TTM
- —
- Dividend yield
- 0.0%
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
| Line | FY2020 Jun 20 | FY2021 Jun 21 | FY2022 Jun 22 | FY2023 Jun 23 | FY2024 Jun 24 | FY2025 Jun 25 | FY2026 Jun 26 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | — | — | 0.11 | 0.07 | 0.40 | 0.56 | 7.62 | 7.62 | |
| Short-term investments | — | — | — | — | 0.01 | 0.00 | — | — | |
| Receivables | — | — | — | — | 0.00 | 0.00 | 0.02 | 0.02 | |
| Current assets | 0.00 | 0.04 | 0.16 | 0.09 | 0.45 | 0.64 | 7.89 | 7.89 | |
| Total assets | 0.01 | 0.13 | 0.57 | 0.33 | 1.15 | 2.94 | 15.79 | 15.79 | |
| Current liabilities | 0.00 | 0.17 | 0.09 | 0.02 | 0.05 | 0.15 | 2.22 | 2.22 | |
| Long-term debt | 0.00 | 0.01 | 0.05 | 0.00 | — | 0.96 | 7.42 | 7.42 | |
| Short-term debt | 0.00 | 0.07 | 0.06 | 0.00 | — | 0.00 | 0.17 | 0.17 | |
| Total liabilities | 0.00 | 0.18 | 0.13 | 0.03 | 0.06 | 1.12 | 11.60 | 11.60 | |
| Shareholders' equity | 0.01 | -0.05 | 0.44 | 0.31 | 1.10 | 1.82 | 4.19 | 4.19 |
USD billions · SEC XBRL
IREN Limited — questions
- How much cash does IREN Limited have?
- $7.6B in cash and cash equivalents as of 2026-06-30.
- How much debt does IREN Limited have?
- $7.4B of long-term debt and $169.4M due within a year as of 2026-06-30.
- What are IREN Limited's total assets?
- $15.8B as of 2026-06-30.
- What is IREN Limited's shareholders' equity?
- $4.2B as of 2026-06-30.
Every figure on this page comes from IREN Limited's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.